The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex complicated synthetic process. Initial routes focused on protein section coupling, utilizing solid-phase https://sabrinabbks029991.xzblogs.com/81058475/creation-and-investigation-implementations-of-retatrutide